Tanaka M, Aiba S, Takahashi K, Tagami H
Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan.
Arch Dermatol Res. 1996 Aug;288(9):495-9. doi: 10.1007/BF02505243.
Although reduced cutaneous reactivities to Candida albicans have been reported in patients with atopic dermatitis (AD), there is still controversy as to whether the in vivo lymphocyte proliferation response is normal or reduced. We have also reported that patients with AD manifest a decreased cutaneous response only to C. albicans antigen in scarification patch tests. The purpose of this study was to examine whether patients with AD show normal lymphocyte transformation responses to C. albicans antigen. Peripheral blood leucocytes (PBL) from 21 patients with AD and 14 healthy control (HC) subjects were cocultured with optimal concentrations of C. albicans antigen and of superantigens (staphylococcal enterotoxin A and B). PBL from the patients with AD showed a significantly lower response to C. albicans antigen, but there was no statistically significant difference in PBL responses to superantigens between the patients with AD and the HC subjects. This decreased proliferative response of PBL was particularly noticeable in those whose RAST scores for C. albicans antigen were high. These results suggest the development of a specific anergy to C. albicans antigen in patients with AD.
虽然有报道称特应性皮炎(AD)患者对白色念珠菌的皮肤反应性降低,但关于体内淋巴细胞增殖反应是正常还是降低仍存在争议。我们也报道过,在划痕斑贴试验中,AD患者仅对白色念珠菌抗原有皮肤反应降低的表现。本研究的目的是检测AD患者对白色念珠菌抗原的淋巴细胞转化反应是否正常。将21例AD患者和14名健康对照(HC)受试者的外周血白细胞(PBL)与最佳浓度的白色念珠菌抗原和超抗原(葡萄球菌肠毒素A和B)共同培养。AD患者的PBL对白色念珠菌抗原的反应显著降低,但AD患者与HC受试者的PBL对超抗原的反应在统计学上无显著差异。PBL这种增殖反应降低在白色念珠菌抗原RAST评分高的患者中尤为明显。这些结果提示AD患者对白色念珠菌抗原产生了特异性无反应性。